Activated estrogen receptor‐mitogen‐activated protein kinases cross talk confer acquired resistance to lapatinib

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-7714|6|6|695-703

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.6, Iss.6, 2015-11, pp. : 695-703

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase‐mitogen‐activated protein kinase signaling pathway

By  

Molecular Carcinogenesis, Vol. 54, Iss. 8, 2015-08 ,pp. : 608-617

John Wiley & Sons Inc

Access to resources Recommend Favorite

Berberine regulates AMP‐activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice

By  

Molecular Carcinogenesis, Vol. 899-1987, Iss. 10, 2015-10 ,pp. : 1096-1109

John Wiley & Sons Inc

Access to resources Recommend Favorite

Berberine regulates AMP‐activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice

By  

Molecular Carcinogenesis, Vol. 54, Iss. 10, 2015-10 ,pp. : 1096-1109

John Wiley & Sons Inc

Access to resources Recommend Favorite

SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1

By  

EMBO Molecular Medicine, Vol. 10, Iss. 2, 2018-02 ,pp. : 219-238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Spatial intra‐tumour heterogeneity in acquired resistance to targeted therapy complicates the use of PDX models for co‐clinical cancer studies

By  

EMBO Molecular Medicine, Vol. 7, Iss. 9, 2015-09 ,pp. : 1087-1089

John Wiley & Sons Inc

Access to resources Recommend Favorite